Grimes & Company’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.6M Buy
120,363
+431
+0.4% +$100K 0.66% 32
2026
Q1
$29.3M Buy
119,932
+5,511
+5% +$1.28M 0.81% 20
2025
Q4
$23.7M Sell
114,421
-3,291
-3% -$651K 0.57% 35
2025
Q3
$21.8M Buy
117,712
+10,731
+10% +$1.84M 0.54% 36
2025
Q2
$16.3M Buy
106,981
+3,544
+3% +$545K 0.44% 50
2025
Q1
$17.2M Buy
103,437
+1,028
+1% +$161K 0.53% 45
2024
Q4
$14.8M Buy
102,409
+1,667
+2% +$258K 0.43% 55
2024
Q3
$16.3M Buy
100,742
+1,776
+2% +$283K 0.44% 49
2024
Q2
$14.5M Buy
98,966
+1,041
+1% +$155K 0.43% 55
2024
Q1
$15.5M Buy
97,925
+2,210
+2% +$352K 0.48% 53
2023
Q4
$15M Buy
95,715
+2,544
+3% +$390K 0.5% 50
2023
Q3
$14.5M Buy
93,171
+346
+0.4% +$57.1K 0.56% 40
2023
Q2
$15.4M Sell
92,825
-1,886
-2% -$304K 0.54% 42
2023
Q1
$14.7M Buy
94,711
+12,027
+15% +$1.94M 0.6% 38
2022
Q4
$14.6M Buy
82,684
+4,960
+6% +$856K 0.62% 29
2022
Q3
$12.7M Buy
77,724
+2,081
+3% +$352K 0.66% 31
2022
Q2
$13.4M Buy
75,643
+2,087
+3% +$372K 0.68% 29
2022
Q1
$13M Sell
73,556
-4,272
-5% -$727K 0.68% 46
2021
Q4
$13.3M Buy
77,828
+7,859
+11% +$1.29M 0.61% 45
2021
Q3
$11.3M Buy
69,969
+970
+1% +$165K 0.49% 57
2021
Q2
$11.4M Buy
68,999
+1,341
+2% +$222K 0.49% 55
2021
Q1
$11.1M Sell
67,658
-1,064
-2% -$172K 0.53% 53
2020
Q4
$10.8M Buy
68,722
+2,269
+3% +$335K 0.56% 51
2020
Q3
$9.89M Buy
66,453
+1,537
+2% +$227K 0.63% 46
2020
Q2
$9.13M Buy
64,916
+229
+0.4% +$33.4K 0.63% 47
2020
Q1
$8.48M Buy
64,687
+1,583
+3% +$225K 0.77% 29
2019
Q4
$9.21M Buy
63,104
+287
+0.5% +$38.9K 0.6% 48
2019
Q3
$8.13M Buy
62,817
+1,001
+2% +$132K 0.58% 47
2019
Q2
$8.61M Buy
61,816
+3,951
+7% +$547K 0.65% 43
2019
Q1
$8.09M Buy
57,865
+1,091
+2% +$146K 0.63% 45
2018
Q4
$7.33M Sell
56,774
-1,052
-2% -$147K 0.72% 37
2018
Q3
$7.99M Buy
57,826
+423
+0.7% +$56.2K 0.64% 48
2018
Q2
$6.96M Buy
57,403
+11,147
+24% +$1.39M 0.62% 53
2018
Q1
$5.93M Buy
46,256
+4,031
+10% +$545K 0.57% 58
2017
Q4
$5.9M Buy
42,225
+7,944
+23% +$1.11M 0.57% 57
2017
Q3
$4.46M Buy
34,281
+22
+0.1% +$2.92K 0.47% 62
2017
Q2
$4.53M Buy
34,259
+580
+2% +$74K 0.51% 60
2017
Q1
$4.2M Sell
33,679
-117
-0.3% -$14K 0.46% 61
2016
Q4
$3.89M Buy
33,796
+463
+1% +$53.5K 0.45% 65
2016
Q3
$3.94M Sell
33,333
-379
-1% -$46K 0.53% 62
2016
Q2
$4.09M Buy
33,712
+240
+0.7% +$27.3K 0.55% 60
2016
Q1
$3.62M Sell
33,472
-3,448
-9% -$357K 0.47% 64
2015
Q4
$3.79M Sell
36,920
-1,007
-3% -$101K 0.51% 56
2015
Q3
$3.54M Sell
37,927
-1,779
-4% -$172K 0.46% 62
2015
Q2
$3.87M Buy
39,706
+912
+2% +$91.3K 0.54% 60
2015
Q1
$3.9M Buy
38,794
+10,081
+35% +$1.03M 0.94% 46
2014
Q4
$3M Buy
28,713
+698
+2% +$73.6K 0.78% 54
2014
Q3
$2.99M Buy
28,015
+991
+4% +$103K 0.78% 56
2014
Q2
$2.83M Buy
27,024
+220
+0.8% +$22.2K 0.74% 55
2014
Q1
$2.63M Buy
26,804
+59
+0.2% +$5.47K 0.74% 56
2013
Q4
$2.45M Buy
26,745
+999
+4% +$92.1K 0.73% 54
2013
Q3
$2.23M Buy
25,746
+739
+3% +$66.3K 0.76% 54
2013
Q2
$2.15M Buy
+25,007
New +$2.12M 0.78% 52

Other funds holding JNJ

Grimes & Company's JNJ Position: Q2 2026 in Review

Grimes & Company increased its Johnson & Johnson (JNJ) stake by 0.36% in Q2 2026, buying an estimated $100K and bringing the position to 120,363 shares worth $30.6M. The position accounts for 0.66% of the portfolio, ranked #32.

Grimes & Company first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 2,259 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Grimes & Company held 120,363 shares of Johnson & Johnson worth $30.6M as of Q2 2026.
  • Grimes & Company bought 431 Johnson & Johnson shares in Q2 2026, an estimated $100K.
  • Johnson & Johnson made up 0.66% of Grimes & Company's portfolio in Q2 2026, its #32 holding.
  • Grimes & Company first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • 2,259 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Grimes & Company's 13F filing for Q2 2026, filed 17 Jul 2026.